Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

SunGard Acquires Pilot Software from TOBAM

Tuesday, January 10, 2012

Yves Choueifaty
Opalesque Industry Update - SunGard has acquired the Pilot solution from TOBAM, a Paris, France-based asset management firm. The acquisition, the terms of which were not disclosed, is not expected to have a material impact on SunGard’s financial results.

The Pilot solution, built and used by TOBAM as its decision support solution for the fund’s principals, is complementary to SunGard’s Asset Arena solution suite, which supports the core functions of the asset management industry including investment management, investment operations and investor servicing.

Yves Choueifaty, president of TOBAM, said, “Regulators and investors continue to demand greater transparency and robust operations from asset management firms. As a result, small-to-mid-sized asset managers are further faced with cost pressures and competition from larger firms. We developed the Pilot solution to help us service high demand clients with increased transparency and reliability. We are proud that these features have been recognized by SunGard.”

Martin Boyd, president of SunGard’s asset management business, said, “SunGard has chosen to acquire Pilot, a comprehensive solution developed and used by portfolio managers, from which to build our solutions for smaller asset managers. We will leverage our innovative technology infrastructure and development framework, rich solutions portfolio and quality assurance testing to further evolve Pilot for this customer base.” Corporate website:: Source
km

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for